Traductions en contexte français - anglais

Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce sever weakness in patients with myasthenia gravis.

Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis.

Anticholinesterases: Effects of anticholinesterase agent may be antagonised.

This medication is from the family of anticholinergics.

The anticholinesterase actions of Neostigmine are reversible.

It is symptomatic and is the first line of treatment.

Cholinesterase inhibitors are given from the stage “mild” Alzheimer’s disease.

Anticholinesterase inhibitors also act on apathy and sleep disorders.

Cholinesterase inhibitors are widely used for the symptomatic treatment of Alzheimer’s disease.

The treatment is based primarily on anticholinesterase drugs that inhibit the enzyme degrading acetylcholine.

a medicine that inhibits cholinesterase by combining with it and so has a cholinergic effect

If possible, cholinesterase inhibitors should be discontinued at least 24 hours before the start of corticosteroid therapy.

Medications: Anticholinesterase medications like pyridostigmine and neostigmine control symptoms.

Anticholinesterase agents are sometimes effective in reversing neuromuscular block induced by aminoglycoside antibiotics.

If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.